A Study to Assess Safety and Efficacy of ASP015K in Participants With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to Methotrexate (MTX)
Clinical trial NCT03660059 · COMPLETED
Trial details
- NCT number
- NCT03660059
- Sponsor
- Astellas Pharma China, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-27
- Primary completion
- 2021-04-01
- Enrollment
- 385
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.